Bristol-Myers Squibb de Mexico S. de R. L. de C.V.
Bristol-Myers Squibb de Mexico S. de R. L. de C.V., a subsidiary of the global biopharmaceutical leader Bristol-Myers Squibb, is headquartered in Mexico (MX) and operates extensively across the region. Founded in the early 2000s, the company has established itself within the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, immunology, and cardiovascular health. Bristol-Myers Squibb de Mexico is renowned for its commitment to research and development, offering unique therapies that address unmet medical needs. With a strong market position, the company has achieved significant milestones, including the launch of groundbreaking treatments that have transformed patient care. Its dedication to advancing healthcare in Mexico underscores its role as a key player in the biopharmaceutical sector.
DitchCarbon Score
How does Bristol-Myers Squibb de Mexico S. de R. L. de C.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bristol-Myers Squibb de Mexico S. de R. L. de C.V.'s score of 49 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bristol-Myers Squibb de Mexico S. de R. L. de C.V.'s reported carbon emissions
Bristol-Myers Squibb de Mexico S. de R. L. de C.V. currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or initiatives documented. This absence of data suggests that the company may still be in the process of establishing or reporting on its climate commitments. In the broader context of the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. While specific initiatives or targets for Bristol-Myers Squibb de Mexico are not detailed, the industry trend leans towards setting ambitious goals for emissions reductions and enhancing sustainability practices. As the company moves forward, it may consider aligning with global standards and frameworks to enhance its climate strategy and transparency in emissions reporting.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bristol-Myers Squibb de Mexico S. de R. L. de C.V. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
